Page 215 - 2019_03-Haematologica-web

IL6ST variants lead to aberrant T-cell phenotype
14. Keupp K, Li Y, Vargel I, et al. Mutations in the interleukin receptor IL11RA cause auto- somal recessive Crouzon-like craniosynos- tosis. Mol Genet Genomic Med. 2013;1(4):223-237.
15. Nieminen P, Morgan NV, Fenwick AL, et al. Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth. Am J Hum Genet. 2011;89(1):67-81.
16. Escary J-L, Perreau J, Duménil D, Ezine S, Brûlet P. Leukaemia inhibitory factor is nec- essary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature. 1993;363(6427):361-364.
17. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. Disruption of the CNTF gene results in motor neuron degen- eration. Nature. 1993;365(6441):27-32.
18. Grimbacher B, Schäffer AA, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999; 65(3):735-744.
19. Xu Y, Kershaw NJ, Luo CS, et al. Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes. J Biol Chem. 2010;285(28):21214-21218.
20. Nguyen HN, Noss EH, Mizoguchi F, et al. Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory medi- ators. Immunity. 2017; 46(2):220-232.
21. Sallusto F, Lanzavecchia A. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol. 2009;39(8):2076-2082.
22. Brodie T, Brenna E, Sallusto F. OMIP-018: Chemokine receptor expression on human T helper cells. Cytometry A. 2013; 83A(6):530-532.
23. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic speci- ficity of human interleukin 17–producing T helper memory cells. Nat Immunol. 2007;8(6):639-646.
24. Béziat V, Li J, Lin J-X, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018;3(24): eaat4956.
25. Frey-Jakobs S, Hartberger JM, Fliegauf M, et al. ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol. 2018;3(24).
26. Zhang Q, Davis JC, Lamborn IT, et al. Combined Immunodeficiency Associated with DOCK8 Mutations. N Engl J Med. 2009;361(21):2046-2055.
27. Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involv- ing the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper- IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-1302.e4.
28. Zhang Q, Boisson B, Béziat V, Puel A, Casanova J-L. Human hyper-IgE syndrome: singular or plural? Mamm Genome. 2018;29(7-8):603-617.
29. Kurth I, Horsten U, Pflanz S, et al. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J Immunol. 2000;164(1):273-282.
30. Hammacher A, Wijdenes J, Hilton DJ, Nicola NA, Simpson RJ, Layton JE. Ligand- specific utilization of the extracellular mem- brane-proximal region of the gp130-related signalling receptors. Biochem J. 2000;345 Pt
1(Pt 1):25-32.
31. Timmermann A, Küster A, Kurth I, Heinrich
PC, Müller-Newen G. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Eur J Biochem. 2002;269(11):2716-2726.
32. Yoshimura T, Takeda A, Hamano S, et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol. 2006;177(8):5377-5385.
33. Schneider R, Yaneva T, Beauseigle D, El- Khoury L, Arbour N. IL-27 increases the pro- liferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells. Eur J Immunol. 2011;41(1):47-59.
34. Kamiya YS, Mizuguchi J, Morishima TN, et al. Generation with enhanced granzyme B T cell + augmentation of effector CD8 aug- mentation of effector CD8 T cell genera- tion with enhanced granzyme B expression by IL-27 1. J Immunol. 2005; 1751686- 1751693.
35. Owaki T, Asakawa M, Morishima N, et al. STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production. J Immunol. 2008;180(5):2903-2911.
36. Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol. 2008; 180(5):2752-2756.
37. Wilson RP, Ives ML, Rao G, et al. STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and func- tion. J Exp Med. 2015;212(6):855-864.
38. Turtle CJ, Delrow J, Joslyn RC, et al. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8 + semi-invariant T cells. Blood. 2011;118(10):2752-2762.
39. Dias J, Sandberg JK, Leeansyah E. Extensive phenotypic analysis, transcription factor profiling, and effector cytokine production of human MAIT Cells by flow cytometry. Methods Mol Biol. 2017;1514:241-56.
40. Ma CS, Chew GYJ, Simpson N, et al. Deficiency of Th17 cells in hyper IgE syn- drome due to mutations in STAT3. J Exp Med. 2008;205(7):1551-1557.
41. Tangye SG, Pillay B, Randall KL, et al. Dedicator of cytokinesis 8–deficient CD4 + T cells are biased to a T H 2 effector fate at theexpenseofTH1andTH17cells.J Allergy Clin Immunol. 2017;139(3):933-49.
42. Keles S, Charbonnier LM, Kabaleeswaran V, et al. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcrip- tion 3 activation and promotes TH17 cell differentiation. J Allergy Clin Immunol. 2016;138(5):1384-1394.e2.
43. Zhou L, Ivanov II, Spolski R, et al. IL-6 pro- grams TH-17 cell differentiation by promot- ing sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8(9): 967-974.
44. Korn T, Bettelli E, Gao W, et al. IL-21 initi- ates an alternative pathway to induce proin- flammatory TH17 cells. Nature. 2007;448(7152):484-487.
45. Ma CS, Avery DT, Chan A, et al. Functional
STAT3 deficiency compromises the genera- tion of human T follicular helper cells. Blood. 2012;119(17):3997-4008.
46. Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell sub- populations from infancy to adulthood. Clin Exp Immunol. 2010;162(2):271-279.
47. Chandesris M-O, Melki I, Natividad A, et al. Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome. Medicine (Baltimore). 2012;91(4):e1-e19.
48. Gernez Y, Freeman AF, Holland SM, et al. Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry. J allergy Clin Immunol Pract. 2018;6(3):996-1001.
49. Engelhardt KR, Gertz ME, Keles S, et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015;136(2):402-412.
50. Dadi H, Jones TA, Merico D, et al. Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11). J Allergy Clin Immunol. 2018;141(5):1818-1830.e2.
51. Ma CA, Stinson JR, Zhang Y, et al. Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet. 2017;49(8):1192- 1201.
52. Ben-Khemis L, Mekki N, Ben-Mustapha I, et al. A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) defi- ciency in Tunisian patients. Mol Immunol. 2017;90:57-63.
53. Zhang Y, Yu X, Ichikawa M, et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol. 2014; 133(5):1400-1409.e5.
54. Sassi A, Lazaroski S, Wu G, et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol. 2014;133(5):1410- 1419.e13.
55. Felgentreff K, Siepe M, Kotthoff S, et al. Severe eczema and Hyper-IgE in Loeys– Dietz-syndrome. Contribution to new find- ings of immune dysregulation in connective tissue disorders. Clin Immunol. 2014;150 (1):43-50.
56. Lyons JJ, Liu Y, Ma CA, et al. ERBIN defi- ciency links STAT3 and TGF- pathway defects with atopy in humans. J Exp Med. 2017;214(3):669-680.
57. Candotti F. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome. J Clin Immunol. 2018;38(1):13-27.
58. Somech R, Lev A, Lee YN, et al. Disruption of thrombocyte and T lymphocyte develop- ment by a mutation in ARPC1B. J Immunol. 2017;199(12):4036-4045.
59. Kahr WHA, Pluthero FG, Elkadri A, et al. Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease. Nat Commun. 2017;8:14816.
60. Kuijpers TW, Tool ATJ, van der Bijl I, et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. J Allergy Clin Immunol. 2017;140(1):273-277.e10.
61. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol. 2012;3:211.
haematologica | 2019; 104(3)
621